Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 1
2004 2
2005 8
2006 9
2007 7
2008 1
2009 5
2010 2
2011 5
2012 3
2013 3
2014 10
2015 9
2016 7
2017 13
2018 2
2019 2
2020 5
2021 10
2022 8
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D; Duration of Treatment for Spondylodiscitis (DTS) study group. Bernard L, et al. Among authors: mulleman d. Lancet. 2015 Mar 7;385(9971):875-82. doi: 10.1016/S0140-6736(14)61233-2. Epub 2014 Nov 5. Lancet. 2015. PMID: 25468170 Clinical Trial.
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.
Bitoun S, Hässler S, Ternant D, Szely N, Gleizes A, Richez C, Soubrier M, Avouac J, Brocq O, Sellam J, de Vries N, Huizinga TWJ, Jury EC, Manson JJ, Mauri C, Matucci A, Hacein Bey Abina S, Mulleman D, Pallardy M, Broët P, Mariette X; ABIRISK Consortium. Bitoun S, et al. Among authors: mulleman d. JAMA Netw Open. 2023 Jul 3;6(7):e2323098. doi: 10.1001/jamanetworkopen.2023.23098. JAMA Netw Open. 2023. PMID: 37436748 Free PMC article.
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.
Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H. Moulin D, et al. Among authors: mulleman d. Ann Rheum Dis. 2024 Feb 15;83(3):312-323. doi: 10.1136/ard-2023-224014. Ann Rheum Dis. 2024. PMID: 38049981 Free PMC article.
[Rheumatology, the multitude of options].
Morel J, Mulleman D. Morel J, et al. Among authors: mulleman d. Med Sci (Paris). 2019 Dec;35(12):1029-1033. doi: 10.1051/medsci/2019204. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903914 Free article. Review. French.
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.
van der Togt CJT, Van den Bemt B, Aletaha D, Alten R, Chatzidionysiou K, Galloway J, Isaac J, Mulleman D, Verschueren P, Vulto AG, Welsing PMJ, Verhoef L, den Broeder AA. van der Togt CJT, et al. Among authors: mulleman d. RMD Open. 2023 Mar;9(1):e002898. doi: 10.1136/rmdopen-2022-002898. RMD Open. 2023. PMID: 36863753 Free PMC article. Review.
Recherche translationnelle dans les pathologies immuno-inflammatoires : quels défis, quels progrès attendre, pour quelles innovations thérapeutiques ?
Joubert JM, Gottenberg JE, Paintaud G; et les membres de la table ronde N° 2 de Giens XXIX; Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D. Joubert JM, et al. Among authors: mulleman d. Therapie. 2014 Jul-Aug;69(4):291-6. doi: 10.2515/therapie/2014049. Therapie. 2014. PMID: 27393224 French. No abstract available.
106 results